TET2 and acute myeloid leukemia: Furthermore, in an orthotopic xenograft AML mouse model, TET2−/− AML cells were subjected to aza‐induced negative selection when co‐injected with TET2+/− AML cells, further implicating aza as an effective monotherapy for TET2 null AML.